MRI Findings After Prostatic Artery Embolization for Treatment of Benign Hyperplasia

Carregando...
Imagem de Miniatura
Citações na Scopus
59
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER ROENTGEN RAY SOC
Citação
AMERICAN JOURNAL OF ROENTGENOLOGY, v.203, n.4, p.813-821, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE. The purpose of this article is to assess and describe the MRI findings after prostatic artery embolization for treatment of benign prostatic hyperplasia. MATERIALS AND METHODS. We retrospectively evaluated 17 patients who underwent prostatic artery embolization as part of different prospective studies to evaluate this alternative treatment of benign prostatic hyperplasia. Clinical results were evaluated by assessment of urinary catheterization and International Prostate Symptom Score (IPSS). Serial MRI examinations were performed, and the prostatic central gland and peripheral zone were evaluated for signal intensity changes and the presence and characteristics of infarcted areas. Statistical analysis was performed with ANOVA for repeated measures and Student t test. RESULTS. All patients had clinical success, as defined by the removal of indwelling urinary catheter or decreased IPSS after embolization. Infarcts were seen in 70.6% of the subjects, exclusively in the central gland, were almost always characterized by hyperintensity on T1-weighted images and predominant hypointensity on T2-weighted images, and became smaller (mean reduction, p < 0.001) and isointense to the remaining of the central gland over time. Volume reduction of the prostate after embolization was significant (averaging 32.0% after 12-18 months; p < 0.001) only in patients with infarcts. No statistically significant association was seen between the development of infarcts and IPSS. CONCLUSION. MRI can be used for assessing the development of infarcts and volume reduction in the prostate after embolization. Further studies are needed to correlate these findings to clinical outcome.
Palavras-chave
benign prostatic hyperplasia, prostate MRI, prostatic artery embolization, prostatic infarct
Referências
  1. Antunes AA, 2013, CARDIOVASC INTER RAD, V36, P978, DOI 10.1007/s00270-013-0611-5
  2. AUA Practice Guidelines Committee, 2003, J UROLOGY, V170, P530
  3. Bagla S, 2014, J VASC INTERV RADIOL, V25, P47, DOI 10.1016/j.jvir.2013.09.010
  4. BARTSCH G, 1979, J UROLOGY, V122, P487
  5. Bdesha AS, 1996, BRIT J UROL, V78, P886, DOI 10.1046/j.1464-410X.1996.23413.x
  6. Bilhim T, 2013, J VASC INTERV RADIOL, V24, P1595, DOI 10.1016/j.jvir.2013.06.003
  7. Bilhim T, 2013, CARDIOVASC INTER RAD, V36, P403, DOI 10.1007/s00270-012-0528-4
  8. Brehmer M, 1997, BRIT J UROL, V80, P123, DOI 10.1046/j.1464-410X.1997.00262.x
  9. Brook OR, 2013, J MAGN RESON IMAGING, V38, P380, DOI 10.1002/jmri.23981
  10. Camara-Lopes G, 2013, INT BRAZ J UROL, V39, P222, DOI 10.1590/S1677-5538.IBJU.2013.02.11
  11. Carnevale FC, 2013, J VASC INTERV RADIOL, V24, P535, DOI 10.1016/j.jvir.2012.12.019
  12. Carnevale FC, 2011, CARDIOVASC INTER RAD, V34, P1330, DOI 10.1007/s00270-011-0136-8
  13. Carnevale FC, 2010, CARDIOVASC INTER RAD, V33, P355, DOI 10.1007/s00270-009-9727-z
  14. Carnevale FC, 2013, CARDIOVASC INTER RAD, V36, P1452, DOI 10.1007/s00270-013-0680-5
  15. DEKLERK DP, 1979, J CLIN INVEST, V64, P842, DOI 10.1172/JCI109532
  16. DeMeritt JS, 2000, J VASC INTERV RADIOL, V11, P767, DOI 10.1016/S1051-0443(07)61638-8
  17. deSouza NM, 2002, RADIOLOGY, V222, P367, DOI 10.1148/radiol.2222010584
  18. Gottfried HW, 1997, BRIT J UROL, V79, P385, DOI 10.1046/j.1464-410X.1997.02814.x
  19. Grossfeld GD, 2000, RADIOL CLIN N AM, V38, P31, DOI 10.1016/S0033-8389(05)70148-2
  20. Histologische Metzger B., 1993, THESIS LUDWIG MAXIMI
  21. Jeon GS, 2009, J VASC INTERV RADIOL, V20, P384, DOI 10.1016/j.jvir.2008.11.014
  22. JONES TJ, 1986, J CLIN PATHOL, V39, P1221, DOI 10.1136/jcp.39.11.1221
  23. Kershaw LE, 2009, J MAGN RESON IMAGING, V29, P641, DOI 10.1002/jmri.21674
  24. McCluggage WG, 2000, INT J GYNECOL PATHOL, V19, P342, DOI 10.1097/00004347-200010000-00008
  25. McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074
  26. McVary KT, 1998, PROSTATE, P2
  27. Pelage JP, 2004, RADIOLOGY, V230, P803, DOI 10.1148/radiol.230303011
  28. Pisco J, 2013, RADIOLOGY, V266, P668, DOI 10.1148/radiol.12111601
  29. Pisco JM, 2011, J VASC INTERV RADIOL, V22, P11, DOI 10.1016/j.jvir.2010.09.030
  30. ROHR HP, 1981, UROL RES, V9, P193
  31. SCHNALL MD, 1990, UROL RADIOL, V12, P109, DOI 10.1007/BF02923982
  32. Slojewski M, 2002, BJU INT, V89, P776, DOI 10.1046/j.1464-410X.2002.02710.x
  33. Sosna J, 2003, ACAD RADIOL, V10, P846, DOI 10.1016/S1076-6332(03)00015-1
  34. Sun F, 2011, AM J ROENTGENOL, V197, P495, DOI 10.2214/AJR.10.5947
  35. Sun F, 2008, RADIOLOGY, V246, P783, DOI 10.1148/radiol.2463070647
  36. Thorpe A, 2003, LANCET, V361, P1359, DOI 10.1016/S0140-6736(03)13073-5
  37. Verma SK, 2010, ABDOM IMAGING, V35, P118, DOI 10.1007/s00261-008-9483-6
  38. Zlotta AR, 1997, J UROLOGY, V157, P894, DOI 10.1016/S0022-5347(01)65077-8